Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Prana Company Profile

07:10 EDT 30th July 2014 | BioPortfolio

Nil

Location

3275 Corporate View
Vista
California
92081
United States of America

Contact

Phone: 760.566.1070
Fax: 760.566.1071
Email: info@prana.com


News Articles [70 Associated News Articles listed on BioPortfolio]

Prana shares soar after brain disorder drug tests well in study

(Reuters) - Prana Biotechnology Ltd said its experimental drug to treat a hereditary degenerative brain disorder met the main goals of safety and tolerability in a mid-stage study, sending Prana...

Prana falls after PBT2 misses in AD trial

Prana Biotechnology Ltd. (ASX:PBT; NASDAQ:PRAN) fell on NASDAQ on Monday after the company reported that PBT2 missed the primary endpoint of reducing beta amyloid plaque levels at one year vs. placebo...

HCW starts Prana Biotechnology at buy

H.C. Wainwright has initiated coverage of Prana Biotechnology (NASDAQ:PRAN; ASX:PBT) with a “buy” rating at one-year price target of $20.50. The ADRs closed at $7.25 on Monday. “In our view, two...

Prana Alzheimer’s Drug Misses Primary Endpoint in Phase 2

Prana Biotechnology released the top-line results of the 12-month Phase 2 imaging trial in Alzheimer’s disease (IMAGINE Trial), based on draft results. Prana’s PBT2 did not meet its pri

HCW ups Prana price target to $33

H.C. Wainwright has raised its price target for “buy-rated” Prana Biotechnology (NASDAQ:PRAN; ASX:PBT) to $33 from $20.50 after the company reported positive results from a Phase 2a Reach2HD trial...

Prana Updates Alzheimer's Development Program

Prana Biotechnology updated its clinical development program for Alzheimer's disease. Prof.

Prana Huntington's Drug Shows Success in Phase 2

Prana Biotechnology announced the results of its Reach2HD Phase 2 clinical trial investigating PBT2 as a treatment for Huntington's disease.

Ahead of the Bell: Prana Biotechnology shares skid

Shares of Prana Biotechnology Ltd. shed most of their value Monday before markets opened and after the Australian drug developer said its most advanced potential treatment missed the main goal in a st...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Prana Biotechnology Limited

Prana Biotechnology was established to commercialise research into Alzheimer's disease and other major age-related neurodegenerative disorders. The Company was incorporated in 1997 and listed on the A...

Prana Biotechnology

Prana Biotechnology has developed a proprietary library of class-leading chemical compounds. This library is combined with a drug development program to explore novel therapeutics in multiple disease...

Prana

Nil

More Information about "Prana" on BioPortfolio

We have published hundreds of Prana news stories on BioPortfolio along with dozens of Prana Clinical Trials and PubMed Articles about Prana for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prana Companies in our database. You can also find out about relevant Prana Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record